Analyst Ratings January 26, 2026

Piper Sandler Lifts Amerant Bancorp Price Target to $25, Cites Stabilization Progress

Analyst keeps Overweight rating as bank shows early signs of recovery despite an EPS shortfall in Q4 2025

By Derek Hwang AMTB
Piper Sandler Lifts Amerant Bancorp Price Target to $25, Cites Stabilization Progress
AMTB

Piper Sandler raised its price objective on Amerant Bancorp Inc to $25 from $22 and reiterated an Overweight rating, citing the bank's focus on stabilizing operations after completing a credit review and implementing efficiency measures. The firm noted a mixed Q4 2025 performance with revenue above expectations but a sizable EPS miss, and highlighted improvements in tangible book value and extensive third-party reviews of the commercial loan book.

Key Points

  • Piper Sandler raised its price target on Amerant Bancorp to $25 from $22 and maintained an Overweight rating, implying about 17% upside from the $21.32 share price; this impacts investor sentiment in regional banking equities.
  • Amerant reported Q4 2025 revenue of $112.17 million, beating estimates by 4.38%, while EPS of $0.07 missed forecasts by 80.56%, creating a mixed earnings signal for financial markets.
  • The firm emphasized stabilization efforts - completion of a credit review, an operational efficiency plan, and third-party review of more than 85% of the commercial loan book - alongside nearly 10% increase in tangible book value per share in 2025.

Piper Sandler has increased its 12-month price target for Amerant Bancorp Inc to $25.00 from $22.00 while maintaining an Overweight rating on the shares. The new target represents roughly 17% upside from the bank's recent market price of $21.32 and is set against data indicating the stock is trading below its Fair Value.

The brokerage pointed to Amerant's strategic emphasis on returning to stability in the wake of its credit review and the ongoing roll-out of an operational efficiency plan. These moves were cited as foundational to the firms view that the bank is moving toward a steadier footing.

On valuation and scale, Amerant carries a market capitalization of $864.72 million and a price-to-book ratio of 0.92, meaning the shares trade below the companys book value despite signs of improvement across certain metrics.

Piper Sandler acknowledged a recent spike in non-performing loans and several non-GAAP charges that affected fourth-quarter 2025 results. Nevertheless, the firm pointed to encouraging early indicators, noting that more than 85% of Amerants commercial loan book has now undergone third-party review. In Piper Sandlers assessment, although non-performing loans and net charge-offs remain elevated, they are not expected to produce quarterly net losses for the bank.

The analyst also highlighted an improvement in tangible book value per share, which rose nearly 10% in 2025. In its modeling, Piper Sandler projects high-single-digit growth in tangible book value per share for both 2026 and 2027.


Amerants most recent public results for the fourth quarter of 2025 showed a mixed picture. Earnings per share came in at $0.07, well below the $0.36 consensus estimate and constituting an 80.56% negative surprise versus expectations. By contrast, revenue for the quarter totaled $112.17 million, ahead of the $107.46 million forecast and representing a 4.38% positive surprise.

These outcomes leave investors with a bifurcated view: top-line strength in the quarter offset by a material shortfall on EPS. The company did not report any updates regarding mergers or acquisitions, and there have been no recent analyst upgrades or downgrades noted for the stock.

Overall, Piper Sandlers updated valuation and continued Overweight stance reflect confidence in the banks path back to stability and capital recovery, tempered by the ongoing credit-related pressures that influenced recent quarterly performance.


Sectors impacted - Regional banking, financial services, and equity markets for mid-cap banks are the areas most directly affected by the developments detailed above.

Risks

  • Elevated non-performing loans and net charge-offs remain a risk to near-term performance and could weigh on the regional banking sector if pressures persist.
  • Several non-GAAP charges affected fourth-quarter 2025 results, introducing uncertainty around reported profitability for the bank and investor assessment of recurring earnings.
  • The significant EPS miss in Q4 2025, despite revenue outperformance, presents earnings volatility that may influence investor confidence in mid-cap bank stocks.

More from Analyst Ratings

Goldman Keeps OLN Neutral at $22 as Olin Signals Rough Q1, Cost Cuts to Cushion Results Feb 2, 2026 Aletheia Capital Starts Coverage on Teradyne With Buy Rating, $400 Target Feb 2, 2026 Needham Lifts Napco Security Price Target to $49 After Robust Q2 Results Feb 2, 2026 Evercore ISI Sticks with Outperform on Apple, Sets $330 Target Backed by App Store and Services Strength Feb 2, 2026 Deutsche Bank Says AppLovin Risk-Reward Looks Better After Google’s Project Genie Shock Feb 2, 2026